Shionogi & Co., Ltd. (SGIOY)
9.15
-0.03
(-0.33%)
USD |
OTCM |
Aug 24, 16:00
Shionogi Enterprise Value : 17.95B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 17.95B |
| August 21, 2026 | 18.00B |
| August 20, 2026 | 17.90B |
| August 19, 2026 | 17.86B |
| August 18, 2026 | 17.30B |
| August 17, 2026 | 17.28B |
| August 14, 2026 | 17.42B |
| August 13, 2026 | 17.37B |
| August 12, 2026 | 17.42B |
| August 11, 2026 | 17.47B |
| August 10, 2026 | 17.49B |
| August 07, 2026 | 17.52B |
| August 06, 2026 | 17.47B |
| August 05, 2026 | 17.16B |
| August 04, 2026 | 17.31B |
| August 03, 2026 | 18.42B |
| July 31, 2026 | 17.76B |
| July 30, 2026 | 18.49B |
| July 29, 2026 | 18.25B |
| July 28, 2026 | 17.44B |
| July 27, 2026 | 17.33B |
| July 24, 2026 | 17.15B |
| July 23, 2026 | 17.06B |
| July 22, 2026 | 17.27B |
| July 21, 2026 | 17.50B |
| Date | Value |
|---|---|
| July 20, 2026 | 17.40B |
| July 17, 2026 | 17.38B |
| July 16, 2026 | 17.23B |
| July 15, 2026 | 17.18B |
| July 14, 2026 | 17.57B |
| July 13, 2026 | 17.10B |
| July 10, 2026 | 17.25B |
| July 09, 2026 | 17.25B |
| July 08, 2026 | 17.32B |
| July 07, 2026 | 17.54B |
| July 06, 2026 | 17.64B |
| July 02, 2026 | 17.08B |
| July 01, 2026 | 16.65B |
| June 30, 2026 | 16.91B |
| June 29, 2026 | 14.56B |
| June 26, 2026 | 14.34B |
| June 25, 2026 | 14.05B |
| June 24, 2026 | 14.64B |
| June 23, 2026 | 14.60B |
| June 22, 2026 | 14.64B |
| June 18, 2026 | 14.76B |
| June 17, 2026 | 14.76B |
| June 16, 2026 | 14.69B |
| June 15, 2026 | 14.90B |
| June 12, 2026 | 14.56B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Daiichi Sankyo Co., Ltd. | 31.92B |
| Takeda Pharmaceutical Co., Ltd. | 85.21B |
| Eisai Co., Ltd. | 8.479B |
| Chugai Pharmaceutical Co., Ltd. | 65.99B |
| Santen Pharmaceutical Co., Ltd. | 3.487B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 613.21M |
| Revenue (Quarterly) | 1.025B |
| Total Expenses (Quarterly) | 411.75M |
| EPS Diluted (Quarterly) | 0.3601 |
| Gross Profit Margin (Quarterly) | 71.45% |
| Profit Margin (Quarterly) | 59.84% |
| Earnings Yield | 10.89% |
| Operating Earnings Yield | 6.87% |
| Normalized Earnings Yield | 10.89 |